Clarifying complex inheritance: apolipoprotein C3 and atherosclerosis

    loading  Checking for direct PDF access through Ovid

Abstract

Purpose of review

To describe some steps in the progress in the molecular biology of a peptide, apolipoprotein C3; its gene mutations that render individuals susceptible or resistant to developing hyperlipidaemia and atherosclerosis.

Recent findings

Data that lead to the development of a new therapeutic agent volanesorsen.

Summary

The agent blocks the function of the mRNA of apolipoprotein C3 and successfully treats severe hypertriglyceridaemia in phase 3 trials (Ionis Pharmaceuticals).

Related Topics

    loading  Loading Related Articles